Dr. Reddy’s Laboratories announces launch of Doxercalciferol Injection in the...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View Article采用Masimo Patient SafetyNet™和rainbow Acoustic Monitoring®的研究调查术后患者的去氧饱和及呼吸过缓发病率
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布,《临床监护和计算杂志》(Journal of Clinical Monitoring and Computing)近期发表了一项研究,日本东京日本医科大学的研究人员采用Masimo Patient SafetyNet™和rainbow Acoustic Monitoring®...
View ArticlePhenomics Health Inc. Acquires Patented Pharmacometabolomic Technology
ANN ARBOR, Mich. Phenomics Health Inc., a bioinformatics platform-based precision medicine company, today announced it has acquired the patented pharmacometabolomic technology portfolio of Precera...
View ArticleAVITA Medical and the Gates Center for Regenerative Medicine at the...
VALENCIA, Calif., MELBOURNE, Australia & AURORA, Colo. AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical...
View ArticleAmipure, the Ultimately Clean K-Beauty Skin Care Brand Launches in the U.S.
SEOUL, South Korea Amipure, a K-beauty skin care brand known for its “clean” ingredients has officially launched sales in North America by introducing its products on Amazon. The South Korean...
View Articleマシモ・ペイシェント・セーフティーネットとrainbowアコースティックモニタリングを使用して術後患者で酸素飽和度低下と緩徐呼吸の発生頻度を究明する研究
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、Journal of Clinical Monitoring and...
View ArticleMerck’s KEYTRUDA® (pembrolizumab) Now Approved in China for First-Line...
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products...
View ArticleAlipay’s Xiang Hu Bao Online Mutual Aid Platform Attracts 100 Million...
HANGZHOU, China Xiang Hu Bao, an online mutual aid platform introduced by Alipay, has attracted over 100 million participants since it was launched just over a year ago, helping health protection in...
View ArticlePharmaron Lists H-Shares on the Hong Kong Stock Exchange
HONG KONG & BEIJING Pharmaron Beijing Co., Ltd. (Stock Code: 300759.SZ/3759.HK) announced today that 117 million H-shares are listed on the Main Board of The Stock Exchange of Hong Kong. This is...
View ArticleCo-Diagnostics JV CoSara Receives Indian Regulatory Approval for Five...
SALT LAKE CITY Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced...
View ArticleBrii Biosciences Expands Therapeutic Focus to Include Neurosciences with...
BEIJING & DURHAM, N.C. Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in China and around the world, today announced two leadership...
View ArticleDr. Reddy’s Laboratories Announces the Launch of Bortezomib for Injection 3.5...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleNanomix Receives CE Mark for Diagnostic Panel That Aids in Rapid...
EMERYVILLE, Calif. Nanomix announced today that the company has received CE Mark for its S1 Assay for the rapid, simultaneous detection and quantification of lactate (LAC), procalcitonin (PCT), and...
View ArticleOncoSec Comments on Disturbing Elements of Alpha Holdings’ Revised...
SAN DIEGO & PENNINGTON, N.J. OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, issued a statement...
View ArticleAJC Organized the ASEAN Services Trade Forum in Tokyo to Discuss the Emerging...
TOKYO The ASEAN-Japan Centre (AJC) held the “ASEAN Services Trade Forum – Health and Social Services –” on 27 November 2019 in Tokyo, Japan. 107 participants from Japanese private sector, government...
View ArticleLYNPARZA® (olaparib) Approved in China as a First-Line Maintenance Therapy in...
KENILWORTH, N.J. AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the companies have received marketing authorization from China’s National...
View ArticleTaro Announces Resignation of Chief Financial Officer
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that it has accepted the resignation of its Chief Financial Officer, Mariano Balaguer,...
View ArticleMetro Pacific Hospitals Completes Investment by KKR
MANILA, Philippines Metro Pacific Investments Corporation (“MPIC”) (PSE: MPI), global investment firm KKR, and GIC, Singapore’s sovereign wealth fund, today announced the completion of investments...
View ArticlePolarityTE Builds Patent Portfolio with New International Patent Grants
SALT LAKE CITY PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that the company has recently...
View ArticleDKT Expands Access to Contraceptives for Safe Sex as HIV/AIDS Impacts 37...
WASHINGTON According to UNAIDS, “Condoms, if easily available and used consistently and correctly, are one of the most effective and inexpensive methods available to reduce the sexual transmission...
View Article